Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Immutep Limited - American Depositary Shares (NQ:IMMP)

0.4455 -0.0145 (-3.15%)

Streaming Delayed Price Updated: 1:16 PM EDT, May 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immutep Limited - American Depositary Shares

< Previous 1 2 3 4 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 17, 2023

We're starting off Wednesday with a look at the biggest pre-market stock movers traders will want to keep an eye on this morning!

Via InvestorPlace

Immutep Receives Approval to Initiate INSIGHT-005 Trial Evaluating Eftilagimod Alpha and Anti-PD-L1 Therapy BAVENCIO®

May 01, 2023

From Immutep Limited

Via GlobeNewswire

7 Best Penny Stocks Under $3 to Buy in April ↗

April 12, 2023

If you have the audacity to consider ultra-speculative opportunities, these ideas for best penny stocks under $3 might be appealing.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 03, 2023

We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!

Via InvestorPlace

Immutep Issues Development Update For Its Lead Cancer Candidate ↗

September 14, 2022

Via Benzinga

Why Are Immutep Shares Trading Higher? ↗

March 30, 2022

Immutep Limited (NASDAQ: IMMP) has

Via Benzinga

Why Did Immutep Ltd Stock Soar Recently?

December 28, 2022

Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product candidate.

Via MarketBeat

Topics Initial Public Offering

Immutep Enters into Second Clinical Trial Collaboration Agreement with Merck KGaA, Darmstadt, Germany, and Pfizer for New Combination Study of its First-in-Class LAG-3 Candidate, Eftilagimod Alpha, and Avelumab to Treat Urothelial Cancer

November 29, 2022

From Immutep Limited

Via GlobeNewswire

Immutep Granted New Patents in Japan and South Korea for First-in-Class LAG-3 Candidate, Eftilagimod Alpha in Chemo-Immunotherapy Combination

November 09, 2022

From Immutep Limited

Via GlobeNewswire

Unusual Options Activity Insight: Immutep ↗

August 09, 2021

Shares of Immutep (NASDAQ:IMMP) saw some unusual options ...

Via Benzinga

Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket ↗

October 04, 2022

Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday.

Via Benzinga

Immutep's Lung Cancer Candidate Shows Encouraging Efficacy As Second-Line Treatment ↗

August 01, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 04, 2022

Via Benzinga

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study ↗

April 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 24, 2022

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...

Via Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

FDA Backs Immutep's Eftilagimod Registrational Trial In Metastatic Breast Cancer ↗

March 10, 2022

Immutep Limited (NASDAQ: IMMP) has received constructive feedback from the FDA regarding its clinical development program for eftilagimod alpha (efti or IMP321) in...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 09, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 10, 2021

Gainers Seres Therapeutics (NASDAQ:MCRB) shares moved upwards by 31.29% to $9.02 during Wednesday's regular session. Trading volume for this security as of 12:30 EST...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 10, 2021

Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6...

Via Benzinga

75 Biggest Movers From Yesterday ↗

November 10, 2021

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 09, 2021

Gainers Frequency Therapeutics (NASDAQ:FREQ) stock rose 10.94% to $7.51 during Tuesday's regular session. The current volume of 277.7K shares is 160.43% of Frequency...

Via Benzinga

58 Stocks Moving In Monday's Mid-Day Session ↗

November 09, 2021

Gainers Dover Motorsports, Inc. (NYSE: DVD) shares climbed 60.3% to $3.59 after Speedway Motorsports announced it will acquire the company for $3.61 per share in cash. TDH...

Via Benzinga

Immutep's Lead Candidate Data In Breast Cancer Trial Fails To Lift The Stock ↗

November 09, 2021

Immutep Limited (NASDAQ: IMMP) has announced final overall survival data (OS) from its Phase 2b AIPAC trial. 227 patients with HER2-negative/HR-positive metastatic...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

August 09, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Immutep Limited - American Depositary Shares (NQ:IMMP)

All News about Immutep Limited - American Depositary Shares